Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Oncology Reviews

Issue 4/2010

Content (5 Articles)

Editorial

Photofrin-mediated photodynamic therapy for treatment of early stage laryngeal malignancies

Vanessa Gayl Schweitzer, Melissa L. Somers

Review

Vγ9Vδ2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies

Serena Meraviglia, Carmela La Mendola, Valentina Orlando, Francesco Scarpa, Giuseppe Cicero, Francesco Dieli

Review

Clinicopathologic characteristics of primary pleural epithelioid hemangioendothelioma

Chad A. Reade, Apar Kishor Ganti, Anne Kessinger

Review

Drug-induced QT interval prolongation in cancer patients

Torben K. Becker, Sai-Ching J. Yeung

Review

Screening of high-risk groups for breast and ovarian cancer in Europe: a focus on the Jewish population

Karen L. Belkić, Miri Cohen, Marcela Márquez, Miriam Mints, Brigitte Wilczek, Anne H. Berman, Enrique Castellanos, Martha Castellanos

Sep 10
Issue: 3/2010
Mar 11
Issue: 1/2011

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits